Trials / Completed
CompletedNCT00895726
Pilot Study of APD209 in Cancer Cachexia
Open-Label, Pilot Phase I/II Study of the Efficacy and Safety of APD209 in Patients With Cachexia and Advanced Malignancy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Acacia Pharma Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: To assess the efficacy of APD209 in adult patients with active cachexia associated with advanced malignancy and not caused by simple starvation. Secondary Objective: To assess the safety of APD209 in patients with advanced malignancy and active cachexia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | APD209 | Oral tablets twice per day for 56 days |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2011-11-01
- Completion
- 2012-01-01
- First posted
- 2009-05-08
- Last updated
- 2012-01-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00895726. Inclusion in this directory is not an endorsement.